CORONA Remedies Limited (BOM:544644)
India · Delayed Price · Currency is INR 1,863.50
+40.85 (2.24%)
At close: Jun 19, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 112.94 billion as of June 22, 2026.
Market Cap
112.94B
Enterprise Value
114.15B
Revenue
14.03B
Ranking
n/a
PE Ratio
61.01
Stock Price
1,863.50
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 112.94B, an increase of 28.39%. That is a compound annual growth rate of 62.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 112.94B | 33.35% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |
| Granules India | 194.73B |
| Caplin Point Laboratories | 190.50B |
| Jubilant Pharmova | 152.96B |
| CORONA Remedies | 114.28B |
| Viyash Scientific | 111.10B |
| Procter & Gamble Health | 104.10B |